UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 281

Sortiert nach

A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era

Blood, 2018-08, Vol.132 (5), p.521-532

2018

Link zum Volltext

Verfügbarkeit prüfen

Effects of Microbial Transfer during Food-Gut-Feces Circulation on the Health of Bombyx mori

Microbiology spectrum, 2022-12, Vol.10 (6), p.e0235722

2022

Link zum Volltext

Verfügbarkeit prüfen

Chemically Programmed Bispecific Antibodies in Diabody Format

The Journal of biological chemistry, 2016-09, Vol.291 (37), p.19661-19673

2016

Link zum Volltext

Verfügbarkeit prüfen

Conventional and Chemically Programmed Asymmetric Bispecific Antibodies Targeting Folate Receptor 1

Frontiers in immunology, 2019-08, Vol.10, p.1994-1994

2019

Link zum Volltext

Verfügbarkeit prüfen

Redirecting cytotoxic T cells with chemically programmed antibodies

Bioorganic & medicinal chemistry, 2020-12, Vol.28 (24), p.115834-115834, Article 115834

2020

Link zum Volltext

Verfügbarkeit prüfen

Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia

Journal for immunotherapy of cancer, 2022-11, Vol.10 (11), p.e004850

2022

Link zum Volltext

Verfügbarkeit prüfen

Cation-π interaction regulates ligand-binding affinity and signaling of integrin α4β7

Proceedings of the National Academy of Sciences - PNAS, 2010-12, Vol.107 (50), p.21388-21393

2010

Link zum Volltext

Verfügbarkeit prüfen

Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1

Proceedings of the National Academy of Sciences - PNAS, 2018-06, Vol.115 (24), p.E5467-E5476

2018

Link zum Volltext

Verfügbarkeit prüfen

Chemically Programmable and Switchable CAR‐T Therapy

Angewandte Chemie (International ed.), 2020-07, Vol.59 (29), p.12178-12185

International ed. in English, 2020

Link zum Volltext

Verfügbarkeit prüfen

Affinity maturation, humanization, and co-crystallization of a rabbit anti-human ROR2 monoclonal antibody for therapeutic applications

The Journal of biological chemistry, 2020-05, Vol.295 (18), p.5995-6006

2020

Link zum Volltext

Verfügbarkeit prüfen

An IgG1-like bispecific antibody targeting CD52 and CD20 for the treatment of B-cell malignancies

Methods (San Diego, Calif.), 2019-02, Vol.154, p.70-76

2019

Link zum Volltext

Verfügbarkeit prüfen

BTK inhibitors, irrespective of ITK inhibition, increase efficacy of a CD19/CD3-bispecific antibody in CLL

Blood, 2021-11, Vol.138 (19), p.1843-1854

2021

Link zum Volltext

Verfügbarkeit prüfen

Expert's views and perspectives: an interview with distinguished investigator Dr. Ira Pastan at the National Cancer Institute at NIH

Antibody therapeutics, 2020-07, Vol.3 (3), p.163-166

2020

Link zum Volltext

Verfügbarkeit prüfen

Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility

Journal of molecular biology, 2017-09, Vol.429 (19), p.2954-2973

2017

Link zum Volltext

Verfügbarkeit prüfen

Targeting Stereotyped B Cell Receptors from Chronic Lymphocytic Leukemia Patients with Synthetic Antigen Surrogates

The Journal of biological chemistry, 2016-04, Vol.291 (14), p.7558-7570

2016

Link zum Volltext

Verfügbarkeit prüfen

Eupolyphaga sinensis walker displays inhibition on hepatocellular carcinoma through regulating cell growth and metastasis signaling

Scientific reports, 2014-07, Vol.4 (1), p.5518-5518, Article 5518

2014

Link zum Volltext

Verfügbarkeit prüfen

A CD19/CD3 Bispecific Antibody Induces Superior T Cell Responses Against Chronic Lymphocytic Leukemia When Combined with Ibrutinib

Blood, 2019-11, Vol.134 (Supplement_1), p.2861-2861

2019

Link zum Volltext

Verfügbarkeit prüfen

CD19/CD3 bispecific antibodies induce potent response against chronic lymphocytic leukemia cells ex vivo

The Journal of immunology (1950), 2017-05, Vol.198 (1_Supplement), p.120-120.17

2017

Link zum Volltext

Verfügbarkeit prüfen

Eupolyphaga sinensis Walker Ethanol Extract Suppresses Cell Growth and Invasion in Human Breast Cancer Cells

Integrative cancer therapies, 2016-03, Vol.15 (1), p.102-112

2016

Link zum Volltext

Verfügbarkeit prüfen

Activity of CD19/CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia

Blood, 2017-12, Vol.130 (Suppl_1), p.799-799

2017

Link zum Volltext

Verfügbarkeit prüfen

Eupolyphaga sinensis Walker inhibits human chronic myeloid leukemia cell K562 growth by inducing G2 –M phase cell cycle arrest and targeting EGFR signaling pathway and in S180 tumor-bearing mice

Environmental toxicology and pharmacology, 2014-05, Vol.37 (3), p.1177-1185

2014

Link zum Volltext

Verfügbarkeit prüfen

A novel compound T7 (N-{4′-[(1E)-N-hydroxyethanimidoyl]-3′,5,6-trimethoxybiphenyl-3-yl}-N′-[4-(3-morpholin-4-ylpropoxy)phenyl]urea) screened by tissue angiogenesis model and its activity evaluation on anti-angiogenesis

Phytomedicine (Stuttgart), 2014-10, Vol.21 (12), p.1675-1683

2014

Link zum Volltext

Verfügbarkeit prüfen

Eupolyphaga sinensis Walker screened by cell membrane chromatography and its inhibition on Hek293/EGFR cells by modulating the EGFR signaling pathway

European journal of integrative medicine, 2014-12, Vol.6 (6), p.741-741

2014

Link zum Volltext

Verfügbarkeit prüfen

Chemically Programmable and Switchable CAR‐T Therapy

Angewandte Chemie, 2020-07, Vol.132 (29), p.12276-12283

2020

Link zum Volltext

Verfügbarkeit prüfen

A novel compound T7 screened by tissue angiogenesis model and its activity evaluation on anti-angiogenesis

Phytomedicine (Stuttgart), 2014-10, Vol.21 (12), p.1675

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 281

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(245)
Mit Volltextzugriff
(260)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(193)
Life Sciences & Biomedicine
(100)
Technology
(70)
Humans
(50)
Physical Sciences
(46)
Materials Science
(41)
Materials Science, Multidisciplinary
(36)
Animals
(34)
Engineering
(28)
Chemistry
(24)
Science & Technology - Other Topics
(21)
Oncology
(15)
Biochemistry & Molecular Biology
(14)
Environmental Sciences & Ecology
(14)
Female
(14)
Nanoscience & Nanotechnology
(14)
Neurosciences & Neurology
(14)
China
(13)
Environmental Sciences
(13)
Immunology
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era

Effects of Microbial Transfer during Food-Gut-Feces Circulation on the Health of Bombyx mori

Chemically Programmed Bispecific Antibodies in Diabody Format

Conventional and Chemically Programmed Asymmetric Bispecific Antibodies Targeting Folate Receptor 1

Redirecting cytotoxic T cells with chemically programmed antibodies

Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia

Cation-π interaction regulates ligand-binding affinity and signaling of integrin α4β7

Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1

Chemically Programmable and Switchable CAR‐T Therapy

Affinity maturation, humanization, and co-crystallization of a rabbit anti-human ROR2 monoclonal antibody for therapeutic applications

An IgG1-like bispecific antibody targeting CD52 and CD20 for the treatment of B-cell malignancies

BTK inhibitors, irrespective of ITK inhibition, increase efficacy of a CD19/CD3-bispecific antibody in CLL

Expert's views and perspectives: an interview with distinguished investigator Dr. Ira Pastan at the National Cancer Institute at NIH

Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility

Targeting Stereotyped B Cell Receptors from Chronic Lymphocytic Leukemia Patients with Synthetic Antigen Surrogates

Eupolyphaga sinensis walker displays inhibition on hepatocellular carcinoma through regulating cell growth and metastasis signaling

A CD19/CD3 Bispecific Antibody Induces Superior T Cell Responses Against Chronic Lymphocytic Leukemia When Combined with Ibrutinib

CD19/CD3 bispecific antibodies induce potent response against chronic lymphocytic leukemia cells ex vivo

Eupolyphaga sinensis Walker Ethanol Extract Suppresses Cell Growth and Invasion in Human Breast Cancer Cells

Activity of CD19/CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia

Eupolyphaga sinensis Walker inhibits human chronic myeloid leukemia cell K562 growth by inducing G2 –M phase cell cycle arrest and targeting EGFR signaling pathway and in S180 tumor-bearing mice

A novel compound T7 (N-{4′-[(1E)-N-hydroxyethanimidoyl]-3′,5,6-trimethoxybiphenyl-3-yl}-N′-[4-(3-morpholin-4-ylpropoxy)phenyl]urea) screened by tissue angiogenesis model and its activity evaluation on anti-angiogenesis

Eupolyphaga sinensis Walker screened by cell membrane chromatography and its inhibition on Hek293/EGFR cells by modulating the EGFR signaling pathway

Chemically Programmable and Switchable CAR‐T Therapy

A novel compound T7 screened by tissue angiogenesis model and its activity evaluation on anti-angiogenesis

Suchergebnisse filtern